Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial reactive oxygen species (mtROS)–generating processes encompass the biochemical pathways within the mitochondria, primarily the electron transport chain (ETC), that produce superoxide and other reactive oxygen species as byproducts of oxidative phosphorylation. The major sites of generation are Complex I (NADH:ubiquinone oxidoreductase) and Complex III (ubiquinol-cytochrome c reductase), where electron leakage to molecular oxygen occurs during electron transfer. While basal levels of mtROS serve as important signaling molecules for cellular adaptation, homeostasis, and immune response, excessive production leads to oxidative stress, damaging mitochondrial DNA, proteins, and lipids. This dysfunction is a hallmark of various pathologies, including neurodegenerative diseases like Parkinson's, cardiovascular disorders such as ischemia-reperfusion injury, and the biological process of aging. Therapeutic strategies include mitochondria-targeted antioxidants like MitoQ and site-specific suppressors of electron leak (S1QELs and S3QELs) that aim to reduce pathological ROS production without compromising the organelle's primary role in energy metabolism.
Scavenging of mitochondrial ROS, inhibition of specific electron leak sites (S1QELs/S3QELs), or modulation of electron transport chain complexes to reduce superoxide production.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial reactive oxygen species–generating processes (mtROS generation).